DoD Ovarian Cancer Clinical Development Award

Funding Opportunity Number: W81XWH-16-OCRP-CDA
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
CFDA Number: 12.420
Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Agency Name: DOD-AMRAA
Closing Date: Aug 10, 2016
Award Ceiling:
Expected Number of Awards: 3
Creation Date: Mar 16, 2016
Funding Opportunity Description: The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof-of-concept demonstrating the potential utility of the proposed product or a prototype/preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required.



Please enter your comment!
Please enter your name here